Related Experiment Video
Updated: Sep 24, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
[G6PD deficiency in a western area of Genoa. Genetic study of 4 new variants]
Insights
This study identified Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency in 900 individuals, detecting 24 males and 16 females with the condition. Four novel G6PD variants were discovered during this population survey.
Area of Science:
- Medical Genetics
- Biochemistry
- Paediatrics
Context:
- Population screening for G6PD deficiency in Genoa, Italy.
- Focus on paediatric patient cohorts.
- Investigating genetic variations in a specific demographic.
Purpose:
- To determine the prevalence of G6PD deficiency.
- To identify and characterize novel variants of G6PD.
- To contribute to the understanding of G6PD genetic diversity.
Summary:
- Screened 900 subjects for G6PD deficiency.
- Detected 24 G6PD deficient males and 16 females (15 heterozygous, 1 homozygous).
- Identified and fully characterized four unique, previously unreported G6PD variants.
Impact:
- Adds to the global knowledge base of G6PD deficiency prevalence.
- Provides new genetic variants for further research into enzyme function and disease mechanisms.
- Highlights the importance of genetic screening in paediatric populations.
Abstract:
Investigations for G6PD deficiency have been carried out among 900 subjects at the Paediatric Departments of the hospitals in Sestri Ponente and Pegli, in the western part of Genoa. 24 G6PD deficient males, 15 heterozygous and 1 homozygous females have been detected. Four variants, which have been encountered during the population survey, are reported. All of them, upon full characterization, were found to be unique new variants.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets

